Pepdox
Studies
Peptides
Calculator
Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg. | Pepdox
Home
/
Search
/
PMID 36691310
Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg.
Postgraduate medicine
2022
PMID: 36691310
View on PubMed
DOI: 10.1080/00325481.2022.2149005
Semaglutide
Authors
Kyrillos, Janine V; O'Neil, Patrick M; Wharton, Sean
Keywords
Semaglutide 2.4 mg
best-practices
cardiometabolic
obesity
primary care
quality of life
weight management